CLASS II ONGOING Device recall · Reported 30 Apr 2025 · FDA Enforcement Report

DxI 9000 Access Immunoassay Analyzer recalled by Beckman Coulter

Beckman Coulter is recalling DxI 9000 Access Immunoassay Analyzer. The recall was initiated on 27 Mar 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 15099590732103, all units run with system software versions SW 1.20.0 and below
Quantity recalled370 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1664-2025
FDA event ID
96554
Recalling firm
Beckman Coulter, Chaska, MN
Classification
Class II
Status
Ongoing
Recall initiated
27 Mar 2025
FDA classified
24 Apr 2025
Reported
30 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

27 Mar 2025Recall initiated by company
24 Apr 2025Classified by FDA+28 days
30 Apr 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

When DxI 9000 Access Immunoassay Analyzer is connected to a host system (laboratory information system (LIS) or middleware) and has accumulated canceled QC test results that were not sent by LIS, the analyzer may lose communication with the host system. The lost connection interrupts sample processing, which delays reporting patient test results and may subsequently delay patient treatment.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Beckman Coulter DxI 9000 Access Immunoassay Analyzer

Where it was distributed

Worldwide distribution.

Questions about this recall

Why was it recalled?

When DxI 9000 Access Immunoassay Analyzer is connected to a host system (laboratory information system (LIS) or middleware) and has accumulated canceled QC test results that were not sent by LIS, the analyzer may lose communication with the host system. The lost connection interrupts sample processing, which delays reporting patient test results and may subsequently delay patient treatment.

Which lots are affected?

UDI/DI 15099590732103, all units run with system software versions SW 1.20.0 and below

Where was it sold?

Worldwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Beckman Coulter

All 336

Other Test Kits & Diagnostics recalls

All 2,663